Lv41
458 积分 2023-06-02 加入
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
4小时前
待确认
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
4小时前
已完结
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
4小时前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
4小时前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
3天前
已完结
Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer
3天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
20天前
已完结
The Born in Guangzhou Cohort Study enables generational genetic discoveries
1个月前
已完结
Sunvozertinib: the next candidate of TKI for NSCLC
1个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
